{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/xcellerater-central-monitoring-infosheet#webpage",
"url": "https://www.fortrea.com/insights/xcellerater-central-monitoring-infosheet",
"name": "Xcellerate® Central Monitoring Infosheet",
"description": "Explore this Fortrea Info Sheet highlighting Xcellerate Central Monitoring, a technology-enabled solution developed to strengthen clinical trial oversight through proactive management of data quality, safety review, and operational risk. Designed to address challenges associated with fragmented systems, reactive processes, and manual reviews, the solution provides near real-time visibility into data anomalies, inconsistencies, and potential safety risks that may impact trial quality and compliance. Xcellerate Central Monitoring supports medical, statistical, and data reviews through advanced analytics, AI-enabled monitoring capabilities, and integrated oversight workflows that help study teams identify emerging risks, improve data integrity, streamline decision-making, and enhance operational efficiency. As part of Fortrea Intelligent Technology, the platform helps clinical teams transition from traditional monitoring approaches toward proactive quality management by enabling earlier interventions, improved oversight, and greater confidence in trial execution across the clinical development lifecycle."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Xcellerate® Central Monitoring Infosheet",
"item": "https://www.fortrea.com/insights/xcellerater-central-monitoring-infosheet"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/xcellerater-central-monitoring-infosheet#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/xcellerater-central-monitoring-infosheet#webpage"
},
"headline": "Xcellerate Central Monitoring: Clinical Trial Oversight, Data Quality Assessment, and Risk Management | Fortrea Info Sheet",
"description": "Explore this Fortrea Info Sheet highlighting Xcellerate Central Monitoring, a technology-enabled solution developed to strengthen clinical trial oversight through proactive management of data quality, safety review, and operational risk. Designed to address challenges associated with fragmented systems, reactive processes, and manual reviews, the solution provides near real-time visibility into data anomalies, inconsistencies, and potential safety risks that may impact trial quality and compliance. Xcellerate Central Monitoring supports medical, statistical, and data reviews through advanced analytics, AI-enabled monitoring capabilities, and integrated oversight workflows that help study teams identify emerging risks, improve data integrity, streamline decision-making, and enhance operational efficiency. As part of Fortrea Intelligent Technology, the platform helps clinical teams transition from traditional monitoring approaches toward proactive quality management by enabling earlier interventions, improved oversight, and greater confidence in trial execution across the clinical development lifecycle.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-06",
"dateModified": "2026-04-06",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/xcellerate-central-monitoring.pdf",
"encodingFormat": "application/pdf"
}
}
]
}